Physician profile
Trang Le
NPI 1942319892
$497.75
in general payments reported to CMS, 2019-2025
9 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2022: $25.27 · 2024: $135 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $108.76 | 2025 | Omnipod |
| Exelixis INC. | $85.56 | 2024 | Cabometyx |
| Shire North American Group INC | $76.87 | 2019 | |
| Radius Health, INC. | $76.30 | 2019-2024 | Tymlos |
| Amgen INC. | $64.33 | 2019 | |
| Sanofi-Aventis U.S. LLC | $34.13 | 2019 | |
| Amryt Pharma Holdings LTD | $25.27 | 2022 | |
| Glaxosmithkline, LLC. | $14.65 | 2019 | |
| Ucb, INC. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trang Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.